TABLE 1.
Characteristics of patients
| Parameter | Resulta |
|---|---|
| No. of patients with: | |
| Cystic fibrosis | 3 |
| Emphysema | 5 |
| Idiopathic pulmonary fibrosis | 4 |
| Scleroderma | 1 |
| Patient age (yr) | 50.9 ± 16.1 (19-70) |
| Wt (kg) | 68.0 ± 15.2 (46-91) |
| Ideal body wt (kg) | 59.6 ± 8.2 (45.5-75.3) |
| Race (Caucasian/other) | 12/0 |
| Gender (male/female) | 7/6 |
| Days posttransplant on day of oral study | 8.5 ± 4.4 (3-19) |
| Alkaline phosphatase (U/liter)b | 82.4 ± 31.8 (54-169) |
| Alanine aminotransferase (U/liter)b | 30.3 ± 8.3 (22-52) |
| Aaspartate aminotransferase (U/liter)b | 28.1 ± 14.5 (20-75) |
| Gamma-glutamyl transpeptidase (U/liter)b | 35.1 ± 19.0 (15-71) |
| Serum creatinine (mg/dl)c | 0.78 ± 0.16 (0.5-1)/0.85 ± 0.22 (0.5-1.1) |
| Creatinine clearance (ml/min)c | 85.6 ± 36.9 (55.6-177.8)/85.7 ± 40.4 (40.5-177.8) |
a
Values are means ± standard deviations (range) unless otherwise specified.
b
Value measured before the transplantation.
c
Shown in the format measurement within 1 day after the transplantation/measurements on the day of the oral study.